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We present the case of a 59-year-old lady, who was found to have an incidental ﬁnding of a lung lesion
on a CxR following percutaneous endoscopic gastroscopy tube insertion. Subsequently a computerised
tomography scan was performed which suggested primary lung malignancy and CT guided biopsy was
arranged. Pathological analysis revealed actinomycosis infection. We discuss the clinical, radiological and
pathological ﬁndings in actinomycosis and how it can often be mistaken for lung cancer. This may put
patients at risk of unnecessary morbidity or even unwarranted surgery and therefore clinicians should
have a high clinical suspicion of thoracic actinomycosis, especially if a patient has underlying risk factors,
such as aspiration.
 2011 Elsevier Ltd. All rights reserved.1. Case report
A 59-year-old lady was referred to the respiratory services
following a routine chest x-ray after the insertion of a percutaneous
endoscopic gastrostomy (PEG) tube. Shehad a background of limited
systemic sclerosis with the symptoms of calcinosis, Raynaud’s
phenomenon, oesophageal dysmotility, scleroderma and telangiec-
tasia [previously known as CREST syndrome]. She was not on any
immunosuppressant medication and on further questioning she
described a history of cough (which she attributed to smoking)
whichwasmore prominent for 3months, butno sputumproduction,
haemoptysis or dyspnoea and her exercise tolerance was limited by
leg pain. She was a smoker of 10e15 cigarettes per day for 40 years
and consumed 8 units of alcohol per week.
On examination she was afebrile, oxygen saturations breathing
room air were 97%, BP 126/71, pulse rate 75 beats per minute. Chest
examination was unremarkable. Her PEG site was clean and
abdominal and cardiovascular examinations were normal. Her
blood investigations revealed: Hb 12.1 g/dL, WBC: 12.8  109/L, Plt
488  109/L, C-reactive protein 61 mg/L and coagulation screen,
urea and electrolytes and liver function tests were all normal.
Her plain chest radiograph is shown in Fig. 1. This demonstrated
an ill-deﬁned opacity in the right mid zone and calcium deposition
in both shoulder joints, with the latter consistent with systemicx: þ44 1896 823476.
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rved.sclerosis. A computerised tomography (CT) scan of the thorax was
performed (Fig. 2). This demonstrated a 31  22 mm opacity in the
right upper lobe abutting the ﬁssure, with spicules extending to the
peripheral pleura. Right hilar lymphadenopathy of up to 16 mm
and a dilated ﬂuid ﬁlled oesophagus were seen. Other abnormali-
ties on CT (not shown here) included right apical pleural thick-
ening, atelectatic change in the right middle lobe, centrilobular
emphysema, PEG tube in situ, three incidental cysts in the spleen
and normal liver, biliary tree, pancreas and kidneys. Of note there
was no evidence of pulmonary ﬁbrosis. Subsequently a CT guided
core-lung biopsy was arranged giving samples for pathological
analysis.
Pathology specimens consisted of four tissue fragments,
macroscopically up to 4 mm in length. The specimens revealed
ﬁbrotic lung tissue, inﬂamed granulation tissue and purulent
debris. Within one of the fragments of purulent debris a colony of
ﬁlamentous type organism is seen which are arranged in a radial
fashion (Fig. 3). Unfortunately this fragment was not present on
further sections stained with gram and PAS. No obvious evidence of
atypia or malignancy was seen. The diagnosis of Actinomycoses
infection of the lung, masquerading as lung cancer, in a patient
with systemic sclerosis and probable undetected aspiration was
made.2. Discussion
Actinomycosis infection in humans was ﬁrst reported in 18571
and the organism responsible for most cases of human disease,
Fig. 1. CxR on presentation following PEG insertion.
Fig. 3. Pathology specimen obtained form CT guided right lung biospy.
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the Greek terms ‘aktino’ (referring to the radiating appearance of
a sulphur granule) and ‘mykos’ (a mycotic disease).2 It is however,
not a mycotic disease but a subacute bacterial infection caused by
ﬁlamentous, gram-positive, non-acid-fast, anaerobic-to-microaero-
philic bacteria and it is often present in normal oral ﬂora. Poor
dental hygiene, dental abscess, any cause of aspiration and struc-
tural lung disease all increase the chance of acquiring the pulmo-
nary form of the disease.3 Further risk factors include diabetes
mellitus, immunosuppression and poor nutritional status. Aspira-
tion of oropharyneal secretions is thought to be the principal
mechanism of developing thoracic actinomyscoses. Between 15
and 50% of all infections involve the lung and differentiation from
lung cancer and tuberculosis can be difﬁcult but in more recent
years a more indolent form of the disease is often found; and the
ﬁnding of an incidental mass on CxR, as in this case, is often the
presenting method.2 Left untreated the disease often progressed
and sinus tracts are formed, with purulent discharge.
Our patient presented to the respiratory services following
a routine CxR. Her symptoms were not particularly troublesome
and her main complaint was of a dry cough. Given her dearth ofFig. 2. Computerised Tomography scan of thorax.infective symptoms the main differential diagnosis was of primary
lung carcinoma, especially given her smoking history. Although her
inﬂammatory markers may have suggested an infective cause she
proceeded to investigations to conﬁrm or refute the diagnosis of
lung cancer, however, the pathological specimen conﬁrmed the
diagnosis of pulmonary actinomycosis. Her co-morbidity of
esophageal dysmotility secondary to systemic sclerosis had given
rise to a ﬂuid ﬁlled, dilated oesophagus, putting her at increased
risk of aspiration and thus actinomycosis infection.
As mentioned the diagnosis of actinomycosis may stem from an
incidental ﬁnding of an opacity and/or mass on CxR. The difﬁculty
in distinguishing this disease from malignancy on either CxR or CT
scan is well described.2,4 Imaging alone is not sufﬁcient tomake the
diagnosis although certain features may be suggestive; in the early
stages the appearances often resemble other pneumonic processes
and the disease may show a peripheral and lower lobe predomi-
nance, as aspiration is thought to be the cause.2 CT ﬁndings include
patchy air-space consolidation, multifocal nodular appearances,
cavitation, pleural thickening, pleural effusions and thoracic
lymphadenopathy. Indicators of the diagnosis on CT include
consolidated areas that contain low attenuation (representing
microabscess or necrotic material that contains ectatic bronchi)
with peripheral enhancement and adjacent pleural thickening.2,5
Left untreated the disease may progress and can invade across
ﬁssures, into bone and surrounding soft tissue often does not
respect deﬁned tissue boundaries. Although MRI is used in other
forms of the disease, such as CNS involvement, the use in thoracic
actinomycosis is limited6 and the imaging technique of choice
remains CT.
The diagnosis of actinomycosis can be made in tissue samples
using Gomori methenamine silver method of staining.2,3 Other
staining techniques that can be employed include p-aminosalicylic
acid, MacCalleneGoodpasture stain, or BrowneBrenn stain.2,3
Characteristically the tissue response shows a mixed suppurative
and granulomatous inﬂammatory reaction and the presence of
‘sulphur granules’ are said to be pathognomic of the disease,
although these can be found in other conditions such as nocardiosis
and chromomycosis.7 The granules are approximately 0.1e1 mm in
diameter and may be seen macroscopically as yellow particles.3
Microscopically at low magniﬁcation they appear as radiating
arrangements of eosinophilic ‘clubs’ and at higher magniﬁcation
they may be seen as a clump of ﬁlamentous actinomycete micro-
colonies surrounded by polymorphonuclear neutrophils.2,3,8
A.R. Akram et al. / Respiratory Medicine CME 4 (2011) 178e180180Our patient was treated with high dose penicillin, initially
intravenously and subsequently orally and the regimen continued
for 6 months. During this time there was improvement in the
radiological appearance of the mass on CxR.3. Conclusion
If treated early the prognosis of thoracic actinomycosis remains
excellent, although many patients may present late resulting in
a higher morbidity and mortality than other forms of actinmy-
coses.2 The difﬁculty in diagnosis and differential diagnosis of lung
cancer may put patients at risk of unnecessary morbidity or even
unwarranted surgery and therefore clinicians should have a high
clinical suspicion of thoracic actinomycosis, especially if a patient
has underlying risk factors for aspiration.
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